Caricamento...
Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinib
Chronic myelogenous leukemia (CML) is a pluripotent stem cell disease characterized by the presence of the Philadelphia chromosome and the bcr-abl gene. The discovery of tyrosine kinase inhibitors (TKIs) revolutionized therapy for CML, such that durable response, increased overall survival, and incr...
Salvato in:
| Pubblicato in: | Biologics |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4777272/ https://ncbi.nlm.nih.gov/pubmed/27013862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S67844 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|